Literature DB >> 6251751

Skin test with Varicella-zoster virus antigen on herpes zoster patients.

S Hata.   

Abstract

Intracutaneous injection of Varicella-zoster (V-Z) viral antigen was performed on 55 patients with herpes zoster. All of them reacted positively after 10 days. The patients in the acute stage responded weakly wereas those in the convalescent phase developed a stronger reaction. The intensity of the reaction did not correlate with the number of days of illness. Positive reactions were observed in those patients who had suffered from herpes zoster several years ago. Complement fixing antibody titers did not parallel the intensity of skin reaction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251751     DOI: 10.1007/bf00403887

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  7 in total

1.  Size of mumps skin test reactions.

Authors:  D N TUCKER; J R OVERMAN
Journal:  J Lab Clin Med       Date:  1958-09

2.  Diagnostic skin test reactions with varicella virus antigen and clinical application of the test.

Authors:  H Kamiya; T Ihara; A Hattori; T Iwasa; M Sakurai; T Izawa; A Yamada; M Takahashi
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.

Authors:  Y Asano; M Takahashi
Journal:  Biken J       Date:  1978-03

4.  Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test.

Authors:  K Baba; H Yabuuchi; H Okuni; M Takahashi
Journal:  Pediatrics       Date:  1978-04       Impact factor: 7.124

5.  Measles skin test and serologic response to intradermal measles antigen.

Authors:  J D Nelson; G Sandusky; F B Peck
Journal:  JAMA       Date:  1966-11-07       Impact factor: 56.272

6.  Skin tests with measles and poliomyelitis vaccines in recipients of inactivated measles virus vaccine. Delayed dermal hypersensitivity.

Authors:  R G Lennon; P Isacson; T Rosales; W R Elsea; D T Karzon; W Winkelstein
Journal:  JAMA       Date:  1967-04-24       Impact factor: 56.272

7.  IMMUNITY IN MUMPS : II. THE DEVELOPMENT OF COMPLEMENT-FIXING ANTIBODY AND DERMAL HYPERSENSITIVITY IN HUMAN BEINGS FOLLOWING MUMPS.

Authors:  J F Enders; S Cohen; L W Kane
Journal:  J Exp Med       Date:  1945-01-01       Impact factor: 14.307

  7 in total
  3 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

Review 2.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

3.  Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster.

Authors:  Y Okuno; Y Takao; Y Miyazaki; F Ohnishi; M Okeda; S Yano; H Kumihashi; Y Gomi; K Maeda; T Ishikawa; Y Mori; H Asada; H Iso; K Yamanishi
Journal:  Epidemiol Infect       Date:  2012-12-10       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.